Skip to Content

Zirgan Approval History

  • FDA approved: Yes (First approved September 15th, 2009)
  • Brand name: Zirgan
  • Generic name: ganciclovir
  • Dosage form: Ophthalmic Gel
  • Company: Sirion Therapeutics, Inc.
  • Treatment for: Keratitis

Zirgan (ganciclovir ophthalmic gel) is a topical ophthalmic antiviral preparation for the treatment of acute herpetic keratitis (dendritic ulcers).

Development History and FDA Approval Process for Zirgan

Sep 16, 2009Approval Sirion Therapeutics Announces FDA Approval of Zirgan (ganciclovir ophthalmic gel) 0.15% for Herpetic Keratitis
Jan 26, 2009Sirion Therapeutics New Drug Application for Ganciclovir is Accepted for Review by the FDA for the Treatment of Ocular Herpes

Disclaimer: Every effort has been made to ensure that the information provided here is accurate, up-to-date and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. This information has been compiled for use by healthcare practitioners and consumers in the United States. The absence of a warning for a given drug or combination thereof in no way should be construed to indicate that the drug or combination is safe, effective or appropriate for any given patient. If you have questions about the substances you are taking, check with your doctor, nurse or pharmacist.